| abstract |
The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts thereof, methods for their preparation, pharmaceutical compositions containing them, and diseases that can be treated with HDL-cholesterol synergists, such as dyslipidemia, atherosclerosis and cardiovascular It relates to the use thereof as a medicament for the treatment and / or prevention of a disease: Formula I In this formula, A 1 to A 3 and R 1 to R 9 are as defined in the specification. |